Covid cases in America have reached one of the lowest points of the pandemic so far, but with fears of the BA.2 'stealth' variant rising in some parts of the country, the Food and Drug Administration () is expected to approve a fourth dose of the vaccine for older Americans. reports that the FDA plans to authorize a second booster dose of both the Pfizer-BioNTech and Moderna vaccines, each would be the fourth dose of the company's vaccine regimen. The Centers for Disease Control and Prevention () is then expected to issue a recommendation to all Americans 50 and older to receive the shot.Once the jab receives approval, any American would be eligible to receive it if they wanted but the government will only recommend it to older age groups for now. A similar process played out with the first booster shot, where it was first only recommended to older age groups before the Omicron variant arrived in late 2021.
Load More
Load More